Tower Research Capital (TRC)’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9K | Sell |
64
-1,319
| -95% | -$430K | ﹤0.01% | 3655 |
|
|
2025
Q1 | $367K | Sell |
1,383
-3,998
| -74% | -$1.06M | 0.01% | 1027 |
|
|
2024
Q4 | $1.27M | Buy |
5,381
+4,840
| +895% | +$1.14M | 0.03% | 519 |
|
|
2024
Q3 | $149K | Sell |
541
-432
| -44% | -$119K | ﹤0.01% | 1903 |
|
|
2024
Q2 | $236K | Sell |
973
-762
| -44% | -$185K | ﹤0.01% | 1938 |
|
|
2024
Q1 | $259K | Sell |
1,735
-4,937
| -74% | -$738K | 0.01% | 1244 |
|
|
2023
Q4 | $1.28M | Buy |
6,672
+1,582
| +31% | +$303K | 0.02% | 708 |
|
|
2023
Q3 | $901K | Sell |
5,090
-4,481
| -47% | -$794K | 0.03% | 580 |
|
|
2023
Q2 | $1.82M | Buy |
9,571
+8,895
| +1,316% | +$1.69M | 0.06% | 255 |
|
|
2023
Q1 | $135K | Sell |
676
-620
| -48% | -$124K | ﹤0.01% | 1604 |
|
|
2022
Q4 | $308K | Sell |
1,296
-1,573
| -55% | -$374K | 0.01% | 993 |
|
|
2022
Q3 | $575K | Sell |
2,869
-10,801
| -79% | -$2.16M | 0.01% | 1033 |
|
|
2022
Q2 | $1.99M | Sell |
13,670
-465
| -3% | -$67.8K | 0.04% | 375 |
|
|
2022
Q1 | $2.31M | Buy |
14,135
+7,404
| +110% | +$1.21M | 0.02% | 535 |
|
|
2021
Q4 | $1.14M | Buy |
6,731
+5,835
| +651% | +$990K | 0.02% | 629 |
|
|
2021
Q3 | $169K | Sell |
896
-1,182
| -57% | -$223K | ﹤0.01% | 1965 |
|
|
2021
Q2 | $352K | Buy |
2,078
+793
| +62% | +$134K | 0.01% | 1465 |
|
|
2021
Q1 | $181K | Sell |
1,285
-6,917
| -84% | -$974K | ﹤0.01% | 2094 |
|
|
2020
Q4 | $1.07M | Buy |
8,202
+3,874
| +90% | +$503K | 0.03% | 488 |
|
|
2020
Q3 | $631K | Buy |
4,328
+2,891
| +201% | +$421K | 0.01% | 1426 |
|
|
2020
Q2 | $213K | Buy |
1,437
+1,412
| +5,648% | +$209K | 0.01% | 1734 |
|
|
2020
Q1 | $3K | Sell |
25
-1,545
| -98% | -$185K | ﹤0.01% | 2438 |
|
|
2019
Q4 | $181K | Buy |
+1,570
| New | +$181K | 0.02% | 625 |
|
|
2019
Q3 | – | Sell |
-828
| Closed | -$60K | – | 4047 |
|
|
2019
Q2 | $60K | Buy |
828
+676
| +445% | +$49K | ﹤0.01% | 1482 |
|
|
2019
Q1 | $14K | Buy |
+152
| New | +$14K | ﹤0.01% | 2464 |
|
|
2018
Q4 | – | Sell |
-1,294
| Closed | -$113K | – | 3789 |
|
|
2018
Q3 | $113K | Buy |
1,294
+1,145
| +768% | +$100K | 0.01% | 1274 |
|
|
2018
Q2 | $15K | Sell |
149
-5,420
| -97% | -$546K | ﹤0.01% | 2576 |
|
|
2018
Q1 | $663K | Buy |
+5,569
| New | +$663K | 0.06% | 337 |
|
|
2017
Q1 | – | Sell |
-1,637
| Closed | -$61K | – | 2999 |
|
|
2016
Q4 | $61K | Buy |
1,637
+795
| +94% | +$29.6K | 0.01% | 1287 |
|
|
2016
Q3 | $57K | Buy |
+842
| New | +$57K | 0.01% | 1067 |
|
|
2016
Q2 | – | Sell |
-40
| Closed | -$3K | – | 4386 |
|
|
2016
Q1 | $3K | Sell |
40
-262
| -87% | -$19.7K | ﹤0.01% | 3040 |
|
|
2015
Q4 | $28K | Buy |
+302
| New | +$28K | ﹤0.01% | 935 |
|
|
2015
Q3 | – | Sell |
-389
| Closed | -$47K | – | 3941 |
|
|
2015
Q2 | $47K | Buy |
389
+162
| +71% | +$19.6K | ﹤0.01% | 1406 |
|
|
2015
Q1 | $24K | Sell |
227
-240
| -51% | -$25.4K | ﹤0.01% | 2093 |
|
|
2014
Q4 | $45K | Sell |
467
-16
| -3% | -$1.54K | ﹤0.01% | 1077 |
|
|
2014
Q3 | $38K | Sell |
483
-763
| -61% | -$60K | ﹤0.01% | 1771 |
|
|
2014
Q2 | $79K | Sell |
1,246
-1,198
| -49% | -$76K | 0.01% | 1026 |
|
|
2014
Q1 | $165K | Buy |
2,444
+1,954
| +399% | +$132K | 0.02% | 472 |
|
|
2013
Q4 | $32K | Sell |
490
-4,818
| -91% | -$315K | 0.01% | 1814 |
|
|
2013
Q3 | $340K | Buy |
5,308
+4,579
| +628% | +$293K | 0.04% | 453 |
|
|
2013
Q2 | $23K | Buy |
+729
| New | +$23K | ﹤0.01% | 1566 |
|